About this Session:
Generative AI is leaving an indelible mark on business, society, and history as we know it. Pushing the skepticism and fear aside, this technology’s potential to revolutionize the pharmaceutical drug development process is right at our fingertips. This won’t be an overnight fix, but pharma organizations are already setting up timelines for implementation and shifting the role of the digital and technology teams to allow for a greater use of AI from early R&D through to commercialization. The sheer computational power of generative AI in analyzing large sets of data and simulating drug interactions will discover potential therapies that have been overlooked in traditional methods, ushering in a drug discovery renaissance for previously untreatable diseases. Hear from pharma’s da Vinci’s as we paint a future where drugs are developed faster, less expensive and more efficacious.